img

Global Ziprasidone Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Ziprasidone Market Insights, Forecast to 2034

Ziprasidone, sold under the brand name Geodon among others, is an atypical antipsychotic that is used for the treatment of schizophrenia as well as acute mania and mixed states associated with bipolar disorder. Its immediate release intramuscular injection form is approved for acute agitation in people with schizophrenia.
Global Ziprasidone market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Ziprasidone industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Ziprasidone key manufacturers include Pfizer, Sandoz, Lupin Pharmaceuticals, Mylan Pharmaceuticals, Apotex, Dr. Reddy's Laboratories, Wockhardt, Aurobindo and Macleods Pharmaceuticals, etc. Pfizer, Sandoz, Lupin Pharmaceuticals are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Ziprasidone were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Ziprasidone market and estimated to attract more attentions from industry insiders and investors.
Ziprasidone can be divided into Oral Capsule and Injection, etc. Oral Capsule is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Ziprasidone is widely used in various fields, such as Hospital and Drug Store, etc. Hospital provides greatest supports to the Ziprasidone industry development. In 2022, global % sales of Ziprasidone went into Hospital filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Ziprasidone market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Ziprasidone market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Sandoz
Lupin Pharmaceuticals
Mylan Pharmaceuticals
Apotex
Dr. Reddy's Laboratories
Wockhardt
Aurobindo
Macleods Pharmaceuticals
Zydus Pharmaceuticals
Segment by Type
Oral Capsule
Injection

Segment by Application


Hospital
Drug Store

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Ziprasidone plant distribution, commercial date of Ziprasidone, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Ziprasidone introduction, etc. Ziprasidone Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Ziprasidone
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Ziprasidone Product Introduction
1.2 Market by Type
1.2.1 Global Ziprasidone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Oral Capsule
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Ziprasidone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Drug Store
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Ziprasidone Sales Estimates and Forecasts 2018-2029
2.2 Global Ziprasidone Revenue by Region
2.2.1 Global Ziprasidone Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Ziprasidone Revenue by Region (2018-2024)
2.2.3 Global Ziprasidone Revenue by Region (2024-2029)
2.2.4 Global Ziprasidone Revenue Market Share by Region (2018-2029)
2.3 Global Ziprasidone Sales Estimates and Forecasts 2018-2029
2.4 Global Ziprasidone Sales by Region
2.4.1 Global Ziprasidone Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Ziprasidone Sales by Region (2018-2024)
2.4.3 Global Ziprasidone Sales by Region (2024-2029)
2.4.4 Global Ziprasidone Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Ziprasidone Sales by Manufacturers
3.1.1 Global Ziprasidone Sales by Manufacturers (2018-2024)
3.1.2 Global Ziprasidone Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Ziprasidone in 2022
3.2 Global Ziprasidone Revenue by Manufacturers
3.2.1 Global Ziprasidone Revenue by Manufacturers (2018-2024)
3.2.2 Global Ziprasidone Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Ziprasidone Revenue in 2022
3.3 Global Key Players of Ziprasidone, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Ziprasidone Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Ziprasidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Ziprasidone, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Ziprasidone, Product Offered and Application
3.8 Global Key Manufacturers of Ziprasidone, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Ziprasidone Sales by Type
4.1.1 Global Ziprasidone Historical Sales by Type (2018-2024)
4.1.2 Global Ziprasidone Forecasted Sales by Type (2024-2029)
4.1.3 Global Ziprasidone Sales Market Share by Type (2018-2029)
4.2 Global Ziprasidone Revenue by Type
4.2.1 Global Ziprasidone Historical Revenue by Type (2018-2024)
4.2.2 Global Ziprasidone Forecasted Revenue by Type (2024-2029)
4.2.3 Global Ziprasidone Revenue Market Share by Type (2018-2029)
4.3 Global Ziprasidone Price by Type
4.3.1 Global Ziprasidone Price by Type (2018-2024)
4.3.2 Global Ziprasidone Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Ziprasidone Sales by Application
5.1.1 Global Ziprasidone Historical Sales by Application (2018-2024)
5.1.2 Global Ziprasidone Forecasted Sales by Application (2024-2029)
5.1.3 Global Ziprasidone Sales Market Share by Application (2018-2029)
5.2 Global Ziprasidone Revenue by Application
5.2.1 Global Ziprasidone Historical Revenue by Application (2018-2024)
5.2.2 Global Ziprasidone Forecasted Revenue by Application (2024-2029)
5.2.3 Global Ziprasidone Revenue Market Share by Application (2018-2029)
5.3 Global Ziprasidone Price by Application
5.3.1 Global Ziprasidone Price by Application (2018-2024)
5.3.2 Global Ziprasidone Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Ziprasidone Market Size by Type
6.1.1 US & Canada Ziprasidone Sales by Type (2018-2029)
6.1.2 US & Canada Ziprasidone Revenue by Type (2018-2029)
6.2 US & Canada Ziprasidone Market Size by Application
6.2.1 US & Canada Ziprasidone Sales by Application (2018-2029)
6.2.2 US & Canada Ziprasidone Revenue by Application (2018-2029)
6.3 US & Canada Ziprasidone Market Size by Country
6.3.1 US & Canada Ziprasidone Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Ziprasidone Sales by Country (2018-2029)
6.3.3 US & Canada Ziprasidone Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Ziprasidone Market Size by Type
7.1.1 Europe Ziprasidone Sales by Type (2018-2029)
7.1.2 Europe Ziprasidone Revenue by Type (2018-2029)
7.2 Europe Ziprasidone Market Size by Application
7.2.1 Europe Ziprasidone Sales by Application (2018-2029)
7.2.2 Europe Ziprasidone Revenue by Application (2018-2029)
7.3 Europe Ziprasidone Market Size by Country
7.3.1 Europe Ziprasidone Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Ziprasidone Sales by Country (2018-2029)
7.3.3 Europe Ziprasidone Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Ziprasidone Market Size
8.1.1 China Ziprasidone Sales (2018-2029)
8.1.2 China Ziprasidone Revenue (2018-2029)
8.2 China Ziprasidone Market Size by Application
8.2.1 China Ziprasidone Sales by Application (2018-2029)
8.2.2 China Ziprasidone Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Ziprasidone Market Size by Type
9.1.1 Asia Ziprasidone Sales by Type (2018-2029)
9.1.2 Asia Ziprasidone Revenue by Type (2018-2029)
9.2 Asia Ziprasidone Market Size by Application
9.2.1 Asia Ziprasidone Sales by Application (2018-2029)
9.2.2 Asia Ziprasidone Revenue by Application (2018-2029)
9.3 Asia Ziprasidone Sales by Region
9.3.1 Asia Ziprasidone Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Ziprasidone Revenue by Region (2018-2029)
9.3.3 Asia Ziprasidone Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Ziprasidone Market Size by Type
10.1.1 Middle East, Africa and Latin America Ziprasidone Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Ziprasidone Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Ziprasidone Market Size by Application
10.2.1 Middle East, Africa and Latin America Ziprasidone Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Ziprasidone Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Ziprasidone Sales by Country
10.3.1 Middle East, Africa and Latin America Ziprasidone Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Ziprasidone Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Ziprasidone Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Ziprasidone Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Pfizer Ziprasidone Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Sandoz
11.2.1 Sandoz Company Information
11.2.2 Sandoz Overview
11.2.3 Sandoz Ziprasidone Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Sandoz Ziprasidone Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sandoz Recent Developments
11.3 Lupin Pharmaceuticals
11.3.1 Lupin Pharmaceuticals Company Information
11.3.2 Lupin Pharmaceuticals Overview
11.3.3 Lupin Pharmaceuticals Ziprasidone Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Lupin Pharmaceuticals Ziprasidone Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Lupin Pharmaceuticals Recent Developments
11.4 Mylan Pharmaceuticals
11.4.1 Mylan Pharmaceuticals Company Information
11.4.2 Mylan Pharmaceuticals Overview
11.4.3 Mylan Pharmaceuticals Ziprasidone Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Mylan Pharmaceuticals Ziprasidone Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Pharmaceuticals Recent Developments
11.5 Apotex
11.5.1 Apotex Company Information
11.5.2 Apotex Overview
11.5.3 Apotex Ziprasidone Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Apotex Ziprasidone Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Apotex Recent Developments
11.6 Dr. Reddy's Laboratories
11.6.1 Dr. Reddy's Laboratories Company Information
11.6.2 Dr. Reddy's Laboratories Overview
11.6.3 Dr. Reddy's Laboratories Ziprasidone Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Dr. Reddy's Laboratories Ziprasidone Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Dr. Reddy's Laboratories Recent Developments
11.7 Wockhardt
11.7.1 Wockhardt Company Information
11.7.2 Wockhardt Overview
11.7.3 Wockhardt Ziprasidone Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Wockhardt Ziprasidone Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Wockhardt Recent Developments
11.8 Aurobindo
11.8.1 Aurobindo Company Information
11.8.2 Aurobindo Overview
11.8.3 Aurobindo Ziprasidone Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Aurobindo Ziprasidone Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Aurobindo Recent Developments
11.9 Macleods Pharmaceuticals
11.9.1 Macleods Pharmaceuticals Company Information
11.9.2 Macleods Pharmaceuticals Overview
11.9.3 Macleods Pharmaceuticals Ziprasidone Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Macleods Pharmaceuticals Ziprasidone Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Macleods Pharmaceuticals Recent Developments
11.10 Zydus Pharmaceuticals
11.10.1 Zydus Pharmaceuticals Company Information
11.10.2 Zydus Pharmaceuticals Overview
11.10.3 Zydus Pharmaceuticals Ziprasidone Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Zydus Pharmaceuticals Ziprasidone Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Zydus Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Ziprasidone Industry Chain Analysis
12.2 Ziprasidone Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Ziprasidone Production Mode & Process
12.4 Ziprasidone Sales and Marketing
12.4.1 Ziprasidone Sales Channels
12.4.2 Ziprasidone Distributors
12.5 Ziprasidone Customers
13 Market Dynamics
13.1 Ziprasidone Industry Trends
13.2 Ziprasidone Market Drivers
13.3 Ziprasidone Market Challenges
13.4 Ziprasidone Market Restraints
14 Key Findings in The Global Ziprasidone Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Ziprasidone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Oral Capsule
Table 3. Major Manufacturers of Injection
Table 4. Global Ziprasidone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Ziprasidone Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Ziprasidone Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Ziprasidone Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Ziprasidone Revenue Market Share by Region (2018-2024)
Table 9. Global Ziprasidone Revenue Market Share by Region (2024-2029)
Table 10. Global Ziprasidone Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Ziprasidone Sales by Region (2018-2024) & (K Units)
Table 12. Global Ziprasidone Sales by Region (2024-2029) & (K Units)
Table 13. Global Ziprasidone Sales Market Share by Region (2018-2024)
Table 14. Global Ziprasidone Sales Market Share by Region (2024-2029)
Table 15. Global Ziprasidone Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Ziprasidone Sales Share by Manufacturers (2018-2024)
Table 17. Global Ziprasidone Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Ziprasidone Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Ziprasidone, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Ziprasidone Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Ziprasidone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Ziprasidone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ziprasidone as of 2022)
Table 23. Global Key Manufacturers of Ziprasidone, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Ziprasidone, Product Offered and Application
Table 25. Global Key Manufacturers of Ziprasidone, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Ziprasidone Sales by Type (2018-2024) & (K Units)
Table 28. Global Ziprasidone Sales by Type (2024-2029) & (K Units)
Table 29. Global Ziprasidone Sales Share by Type (2018-2024)
Table 30. Global Ziprasidone Sales Share by Type (2024-2029)
Table 31. Global Ziprasidone Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Ziprasidone Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Ziprasidone Revenue Share by Type (2018-2024)
Table 34. Global Ziprasidone Revenue Share by Type (2024-2029)
Table 35. Ziprasidone Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Ziprasidone Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Ziprasidone Sales by Application (2018-2024) & (K Units)
Table 38. Global Ziprasidone Sales by Application (2024-2029) & (K Units)
Table 39. Global Ziprasidone Sales Share by Application (2018-2024)
Table 40. Global Ziprasidone Sales Share by Application (2024-2029)
Table 41. Global Ziprasidone Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Ziprasidone Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Ziprasidone Revenue Share by Application (2018-2024)
Table 44. Global Ziprasidone Revenue Share by Application (2024-2029)
Table 45. Ziprasidone Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Ziprasidone Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Ziprasidone Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Ziprasidone Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Ziprasidone Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Ziprasidone Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Ziprasidone Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Ziprasidone Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Ziprasidone Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Ziprasidone Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Ziprasidone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Ziprasidone Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Ziprasidone Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Ziprasidone Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Ziprasidone Sales by Country (2024-2029) & (K Units)
Table 60. Europe Ziprasidone Sales by Type (2018-2024) & (K Units)
Table 61. Europe Ziprasidone Sales by Type (2024-2029) & (K Units)
Table 62. Europe Ziprasidone Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Ziprasidone Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Ziprasidone Sales by Application (2018-2024) & (K Units)
Table 65. Europe Ziprasidone Sales by Application (2024-2029) & (K Units)
Table 66. Europe Ziprasidone Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Ziprasidone Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Ziprasidone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Ziprasidone Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Ziprasidone Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Ziprasidone Sales by Country (2018-2024) & (K Units)
Table 72. Europe Ziprasidone Sales by Country (2024-2029) & (K Units)
Table 73. China Ziprasidone Sales by Type (2018-2024) & (K Units)
Table 74. China Ziprasidone Sales by Type (2024-2029) & (K Units)
Table 75. China Ziprasidone Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Ziprasidone Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Ziprasidone Sales by Application (2018-2024) & (K Units)
Table 78. China Ziprasidone Sales by Application (2024-2029) & (K Units)
Table 79. China Ziprasidone Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Ziprasidone Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Ziprasidone Sales by Type (2018-2024) & (K Units)
Table 82. Asia Ziprasidone Sales by Type (2024-2029) & (K Units)
Table 83. Asia Ziprasidone Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Ziprasidone Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Ziprasidone Sales by Application (2018-2024) & (K Units)
Table 86. Asia Ziprasidone Sales by Application (2024-2029) & (K Units)
Table 87. Asia Ziprasidone Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Ziprasidone Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Ziprasidone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Ziprasidone Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Ziprasidone Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Ziprasidone Sales by Region (2018-2024) & (K Units)
Table 93. Asia Ziprasidone Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Ziprasidone Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Ziprasidone Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Ziprasidone Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Ziprasidone Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Ziprasidone Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Ziprasidone Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Ziprasidone Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Ziprasidone Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Ziprasidone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Ziprasidone Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Ziprasidone Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Ziprasidone Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Ziprasidone Sales by Country (2024-2029) & (K Units)
Table 107. Pfizer Company Information
Table 108. Pfizer Description and Major Businesses
Table 109. Pfizer Ziprasidone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Pfizer Ziprasidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Pfizer Recent Developments
Table 112. Sandoz Company Information
Table 113. Sandoz Description and Major Businesses
Table 114. Sandoz Ziprasidone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Sandoz Ziprasidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Sandoz Recent Developments
Table 117. Lupin Pharmaceuticals Company Information
Table 118. Lupin Pharmaceuticals Description and Major Businesses
Table 119. Lupin Pharmaceuticals Ziprasidone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Lupin Pharmaceuticals Ziprasidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Lupin Pharmaceuticals Recent Developments
Table 122. Mylan Pharmaceuticals Company Information
Table 123. Mylan Pharmaceuticals Description and Major Businesses
Table 124. Mylan Pharmaceuticals Ziprasidone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Mylan Pharmaceuticals Ziprasidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Mylan Pharmaceuticals Recent Developments
Table 127. Apotex Company Information
Table 128. Apotex Description and Major Businesses
Table 129. Apotex Ziprasidone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Apotex Ziprasidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Apotex Recent Developments
Table 132. Dr. Reddy's Laboratories Company Information
Table 133. Dr. Reddy's Laboratories Description and Major Businesses
Table 134. Dr. Reddy's Laboratories Ziprasidone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Dr. Reddy's Laboratories Ziprasidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Dr. Reddy's Laboratories Recent Developments
Table 137. Wockhardt Company Information
Table 138. Wockhardt Description and Major Businesses
Table 139. Wockhardt Ziprasidone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Wockhardt Ziprasidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Wockhardt Recent Developments
Table 142. Aurobindo Company Information
Table 143. Aurobindo Description and Major Businesses
Table 144. Aurobindo Ziprasidone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Aurobindo Ziprasidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Aurobindo Recent Developments
Table 147. Macleods Pharmaceuticals Company Information
Table 148. Macleods Pharmaceuticals Description and Major Businesses
Table 149. Macleods Pharmaceuticals Ziprasidone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. Macleods Pharmaceuticals Ziprasidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Macleods Pharmaceuticals Recent Developments
Table 152. Zydus Pharmaceuticals Company Information
Table 153. Zydus Pharmaceuticals Description and Major Businesses
Table 154. Zydus Pharmaceuticals Ziprasidone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 155. Zydus Pharmaceuticals Ziprasidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Zydus Pharmaceuticals Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Ziprasidone Distributors List
Table 160. Ziprasidone Customers List
Table 161. Ziprasidone Market Trends
Table 162. Ziprasidone Market Drivers
Table 163. Ziprasidone Market Challenges
Table 164. Ziprasidone Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Ziprasidone Product Picture
Figure 2. Global Ziprasidone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Ziprasidone Market Share by Type in 2022 & 2029
Figure 4. Oral Capsule Product Picture
Figure 5. Injection Product Picture
Figure 6. Global Ziprasidone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Ziprasidone Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Drug Store
Figure 10. Ziprasidone Report Years Considered
Figure 11. Global Ziprasidone Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Ziprasidone Revenue 2018-2029 (US$ Million)
Figure 13. Global Ziprasidone Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Ziprasidone Revenue Market Share by Region (2018-2029)
Figure 15. Global Ziprasidone Sales 2018-2029 ((K Units)
Figure 16. Global Ziprasidone Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Ziprasidone Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Ziprasidone Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Ziprasidone Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Ziprasidone Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Ziprasidone Sales YoY (2018-2029) & (K Units)
Figure 22. China Ziprasidone Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Ziprasidone Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Ziprasidone Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Ziprasidone Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Ziprasidone Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Ziprasidone Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Ziprasidone in the World: Market Share by Ziprasidone Revenue in 2022
Figure 29. Global Ziprasidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Ziprasidone Sales Market Share by Type (2018-2029)
Figure 31. Global Ziprasidone Revenue Market Share by Type (2018-2029)
Figure 32. Global Ziprasidone Sales Market Share by Application (2018-2029)
Figure 33. Global Ziprasidone Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Ziprasidone Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Ziprasidone Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Ziprasidone Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Ziprasidone Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Ziprasidone Revenue Share by Country (2018-2029)
Figure 39. US & Canada Ziprasidone Sales Share by Country (2018-2029)
Figure 40. U.S. Ziprasidone Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Ziprasidone Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Ziprasidone Sales Market Share by Type (2018-2029)
Figure 43. Europe Ziprasidone Revenue Market Share by Type (2018-2029)
Figure 44. Europe Ziprasidone Sales Market Share by Application (2018-2029)
Figure 45. Europe Ziprasidone Revenue Market Share by Application (2018-2029)
Figure 46. Europe Ziprasidone Revenue Share by Country (2018-2029)
Figure 47. Europe Ziprasidone Sales Share by Country (2018-2029)
Figure 48. Germany Ziprasidone Revenue (2018-2029) & (US$ Million)
Figure 49. France Ziprasidone Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Ziprasidone Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Ziprasidone Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Ziprasidone Revenue (2018-2029) & (US$ Million)
Figure 53. China Ziprasidone Sales Market Share by Type (2018-2029)
Figure 54. China Ziprasidone Revenue Market Share by Type (2018-2029)
Figure 55. China Ziprasidone Sales Market Share by Application (2018-2029)
Figure 56. China Ziprasidone Revenue Market Share by Application (2018-2029)
Figure 57. Asia Ziprasidone Sales Market Share by Type (2018-2029)
Figure 58. Asia Ziprasidone Revenue Market Share by Type (2018-2029)
Figure 59. Asia Ziprasidone Sales Market Share by Application (2018-2029)
Figure 60. Asia Ziprasidone Revenue Market Share by Application (2018-2029)
Figure 61. Asia Ziprasidone Revenue Share by Region (2018-2029)
Figure 62. Asia Ziprasidone Sales Share by Region (2018-2029)
Figure 63. Japan Ziprasidone Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Ziprasidone Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Ziprasidone Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Ziprasidone Revenue (2018-2029) & (US$ Million)
Figure 67. India Ziprasidone Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Ziprasidone Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Ziprasidone Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Ziprasidone Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Ziprasidone Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Ziprasidone Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Ziprasidone Sales Share by Country (2018-2029)
Figure 74. Brazil Ziprasidone Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Ziprasidone Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Ziprasidone Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Ziprasidone Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Ziprasidone Revenue (2018-2029) & (US$ Million)
Figure 79. Ziprasidone Value Chain
Figure 80. Ziprasidone Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries